Fda approval

Drugs@FDA includes most of the drug products approved since 1939. The majority of patient information, labels, approval letters, reviews, and other information are available for drug products ...
Trends
Drug Trials Snapshots is part of an overall FDA effort to make demographic data more available and transparent. Drug Trials Snapshots provide consumers with information about who participated in ...
The drug establishments current registration site is a publication of currently registered establishments which manufacture, prepare, propagate, compound or process drugs that are distributed in ...
Drugs@FDA Includes information about drugs approved for human use in the United States: Drug information, Regulatory history, Most recent FDA-approved Prescribing Information and patient labeling, and
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
For a reference list of established pharmacologic classes (EPCs) and attributes that define a pharmacologic class (i.e., mechanism of action, physiologic effect, chemical structure), click here & ×
To find out if a drug is approved by FDA, consumers can use two different Internet sites: Drugs@FDA lists most prescription and over-the-counter (OTC) drug products approved since 1939. Drugs@FDA ...
Human drugs and therapeutic biologicals (proteins and other products derived from living sources used for therapeutic purposes) Drug Approval Reports by Month. Drugs@FDA. Postmarket Drug Safety ...
The European Medicines Agency has been making clinical trial data available on request since November 2010,3 and next year, notwithstanding legal challenges, it will expand access by making data publicly available for download from its website.4 5...
Imdelltra (tarlatamab-dlle) for Injection. Company: Amgen Inc. Date of Approval: May 16, 2024 Treatment for: Small Cell Lung Cancer Imdelltra (tarlatamab-dlle) is a first-in-class, bispecific delta-like ligand 3 (DLL3)-directed CD3 T cell engager...
See more